[go: up one dir, main page]

WO2018138913A1 - Preservation solution and sample preservation method using said preservation solution, in particular preservation solution for sample dna and chemical substance such as organic acid or polyamine and preservation method using said preservation solution - Google Patents

Preservation solution and sample preservation method using said preservation solution, in particular preservation solution for sample dna and chemical substance such as organic acid or polyamine and preservation method using said preservation solution Download PDF

Info

Publication number
WO2018138913A1
WO2018138913A1 PCT/JP2017/003189 JP2017003189W WO2018138913A1 WO 2018138913 A1 WO2018138913 A1 WO 2018138913A1 JP 2017003189 W JP2017003189 W JP 2017003189W WO 2018138913 A1 WO2018138913 A1 WO 2018138913A1
Authority
WO
WIPO (PCT)
Prior art keywords
preservation
solution
preservation solution
analysis
mol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2017/003189
Other languages
French (fr)
Japanese (ja)
Inventor
忠生 國弘
長島 浩二
貴義 久田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Technosuruga Laboratory Co ltd
Original Assignee
Technosuruga Laboratory Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technosuruga Laboratory Co ltd filed Critical Technosuruga Laboratory Co ltd
Priority to PCT/JP2017/003189 priority Critical patent/WO2018138913A1/en
Publication of WO2018138913A1 publication Critical patent/WO2018138913A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids

Definitions

  • At least one of chemical substances such as DNA, organic acids and polyamines present in living bodies such as humans and animals and in environments such as water systems, soils, and air is stable at room temperature (about 1 to 40 ° C.). Relates to a preservable storage solution.
  • the present invention also relates to a specimen storage method using the storage solution.
  • microorganisms are considered to be able to separate only about 1% existing on the earth, and the remaining 99% are in a VNC (viable but non-culturable) state, which means that they are in a “living but unculturable” state.
  • VNC viable but non-culturable
  • Such microorganisms that are incapable of culturing are understood as unculturable microorganisms and difficult-to-cultivate microorganisms. In other words, it means that there are many microorganisms that require unknown growth factors for culturing and microorganisms that are impossible or extremely difficult to purely culture.
  • various molecular biological techniques using DNA that do not require culturing have been developed and used.
  • the microbial community structure differs from that at the time of collection depending on the temperature and method of storage from the collection of the specimen to analysis. It is an important issue to know the true microbial community structure to stably store and transport the DNA at room temperature without changing the DNA of the microbial community in the specimen at the time of collection.
  • RNA polymorphism analysis Various molecular biological methods using this DNA include real-time PCR analysis, metagenomic analysis using next-generation sequencers, microbial community structure analysis such as T-RFLP analysis and DGGE analysis, DNA base sequence analysis of microorganism culture strains and strains There are RAPD analysis and microsatellite analysis, which are DNA polymorphism analysis methods for identifying the above.
  • Quantitative analysis of chemical substances includes liquid chromatography, gas chromatography, capillary electrophoresis, and analysis combining these mass spectrometers.
  • sample collection is required to suppress the growth, death, and decomposition of microorganisms and the oxidation, decomposition, and volatilization of chemical substances. It was common to store frozen immediately. Therefore, it is virtually impossible to collect specimens in places where refrigeration equipment is difficult to install, and specimens can also be used in homes where it is difficult to freeze and store biological specimens such as feces due to sanitary problems. The collection was difficult.
  • pretreatment, analysis and analysis should be started immediately after refrigerated storage in order to conduct microbial community structure analysis reflecting the state at the time of collection and physicochemical analysis of organic acids, polyamines, etc.
  • preparation for analysis and analysis and handling of a large number of specimens become complicated, and when much time is required, it is difficult to immediately analyze and analyze.
  • the inventors cannot proliferate the collected specimen by denaturing the biological cell wall protein in an aqueous solution containing a protein denaturant, a DNA degrading enzyme inactivator, a chelating agent, etc.
  • NAGASHIMA K.
  • HISADA T.
  • SATOU M.
  • MOCHIZUKI J.
  • NAGASHIMA K.
  • MOCHIZUKI. J.
  • HISADA T.
  • SUZUKI S.
  • SHIMOMURA K.
  • the present invention can meet the above-mentioned demands, and has the following configuration. That is, (1) From three types of reagent groups consisting of 4 mol / dm 3 guanidine thiocynate, 0.1 mol / dm 3 Tris-HCl having a pH of 7.0 to 9.0, and 0.04 mol / dm 3 EDTA, It is a preservation solution obtained by mixing at least one selected reagent. In addition, 0.1 mol / dm 3 Tris-HCl is more preferably set to pH 8.0. (2) A storage solution characterized by storing at least one of DNA and a chemical substance such as an organic acid or polyamines in addition to the above-described configuration of the storage solution.
  • a storage method comprising: adding a storage solution having the above-described configuration to a specimen, and storing the specimen at room temperature.
  • the storage solution contains 4 mol / dm 3 guanidine thiocynate reagent, and after the storage solution is added to the specimen, the final concentration of guanidine thiocynate in the storage solution is 0.01 mol. / Dm 3 or more, and the volume of the specimen is 50% or less with respect to the volume of the storage solution. Note that the final concentration of guanidine thiocyanate in 0.15mol / dm 3 ⁇ 0.75mol / dm 3, the capacity of the specimen is below 25% relative to volume of the stock solution, but it is more preferable.
  • a novel storage solution capable of stably storing at least one of DNA and a chemical substance at room temperature. It is possible to provide a preservation solution capable of preserving DNA constituent ratios or chemical substances such as organic acids and polyamines, or DNA and DNA constituent ratios and chemical substances such as organic acids and polyamines. is there.
  • At least one of the sample DNA and the chemical substance can be stably stored and transported at room temperature, and the microbial community structure analysis, DNA and DNA using molecular biological techniques It is possible to newly provide a storage method that can use at least one of the specimens immersed in a solution for the physicochemical analysis of chemical substances such as composition ratios, organic acids, and polyamines.
  • FIG. 1 “Comparison of fecal microbial community structure (fungal flora) after storage for 7 days at 30 ° C in a storage solution at the final concentration of each of guanidineine thiocynate by freezing and T-RFLP analysis”
  • FIG. The vertical axis shows the abundance ratio of various bacterial species in feces.
  • FIG. The vertical axis shows the abundance ratio of various bacterial species in feces.
  • the preservation solution in the present embodiment includes three types consisting of 4 mol / dm 3 guanidine thiocynate, pH 7.0 to 9.0 mol 0.1 mol / dm 3 Tris-HCl, and 0.04 mol / dm 3 EDTA. From the reagent group, at least one selected reagent is mixed. In addition, 0.1 mol / dm 3 Tris-HCl is more preferably set to pH 8.0.
  • the storage method in the present embodiment is characterized in that the above-described storage solution is added to a specimen, and at least one of the DNA of the specimen and a chemical substance such as an organic acid or a polyamine is stored at room temperature. .
  • the storage solution contains 4 mol / dm 3 guanidine thiocynate reagent, and after the storage solution is added to the specimen, the final concentration of guanidine thiocynate in the storage solution is 0.01 mol / dm 3 or more.
  • the volume of the specimen is 50% or less with respect to the volume of the storage solution.
  • Samples include soils, sludges, liquids, etc. of environmental samples including various organisms, and feces, saliva, blood, etc. of biological samples.
  • the stool was collected so that the stool concentration (specimen amount) was 250 g / dm 3 (25%).
  • the collected stool samples are stored at 30 ° C. for 7 days, followed by comparison of microbial community structure (microflora) by T-RFLP analysis and comparison of organic acids by liquid chromatography (succinic acid, lactic acid, formic acid, acetic acid, propion) Acid, iso-butyric acid, n-butyric acid, iso-valeric acid, n-valeric acid).
  • the examination conditions are shown in Table 1.
  • Microbial community structure (microflora) analysis by T-RFLP analysis is to extract the total bacterial DNA in feces, label the bacterial 16S rRNA gene region with forward and reverse primers, and either primer with fluorescent dye, After performing PCR amplification and cleaving with a restriction enzyme, the fluorescently labeled terminal DNA fragments cleaved using a capillary sequencer are fractionated, and the length and relative amount of each DNA fragment are analyzed to determine the bacterial community structure. It is a method of examining.
  • Example result 1 The results are shown in FIGS. In both the microbial community structure (bacteria flora) analysis and the physicochemical analysis of organic acids, in 2 subjects, which preservation of 0.2 mol / dm 3 or more (final concentration after stool collection 0.15 mol / dm 3 or more) The solution also preserved the microbial community structure (bacteria flora) and the amount of various organic acids, indicating that there was no difference from frozen storage. In the subject, iso-butyric acid, iso-valeric acid, and n-valeric acid were not detected. However, the same study using 0.2 mol / dm 3 stock solution in other subjects showed that iso-butyric acid, iso-valeric acid, and n-valeric acid were also stably retained (data) Not shown).
  • guanidine thiocynate was added to a solution containing 0.1 mol / dm 3 Tris-HCl (pH 8.0), 0.04 mol / dm 3 EDTA and 0.2 mol / dm 3 to 1 mol / dm 3 of guanidine thiocynate.
  • Tris-HCl pH 8.0
  • 0.04 mol / dm 3 EDTA 0.04 mol / dm 3 EDTA
  • 0.2 mol / dm 3 1 mol / dm 3 of guanidine thiocynate.
  • the microbial community structure can be maintained and preserved, by dissolving the cell membranes of the microorganisms of infectious disease samples and clinical samples to make them unable to grow or infect, it becomes possible to handle safely without restrictions on transportation. It was also confirmed that it can be used for microbial community structure (bacteria flora) analysis and microbial gene analysis (identification, classification, strain identification) using various molecular biological techniques.
  • microbial community structure bacteria flora
  • microbial community structure can be maintained and preserved, real-time PCR analysis, metagenomic analysis using next-generation sequencers, microbial community structure analysis such as T-RFLP analysis and DGGE analysis, DNA base sequence analysis of biological culture strains and strain identification Specimens that can be used for various molecular biology techniques using DNA such as RAPD analysis and microsatellite analysis, which are DNA polymorphism analysis techniques to be performed, and that enable specimens to be collected at various locations
  • a combined product such as a collection container, a specimen transport container that enables the specimen to be transported at room temperature, and a specimen storage container that enables the specimen to be stored at room temperature can be expected.
  • products that can handle infectious disease samples and clinical samples can be expected.
  • Example Method 2 Next, a saliva specimen was prepared by adding 1.5 ⁇ mol / dm 3 polyamines standard 30 mm 3 to saliva 30 mm 3 and H 2 O as a control, and each storage solution 30 mm 3 as a control, and immediately after addition and at room temperature. Changes in polyamines after storage for ⁇ 2 weeks were measured. Table 3 shows the conditions for studying the stock solution.
  • the physicochemical analysis of polyamines was carried out by adding acetonitrile (MeCN) 120 mm 3 and 70 nmol / dm 3 diaminohexane to each saliva sample, deproteinizing it, centrifuging at 3000 g for 5 minutes, and using the supernatant as the sample solution, 40 mmol / dm 3 DBD-F in acetonitrile (90 mm 3) and 100 mmol / dm 3 triethylamine aqueous solution (60 mm 3) were added, and after derivatizing the polyamine at 60 ° C. for 30 minutes, 12 types of polyamines were analyzed by a high performance liquid chromatogram mass spectrometer. The analysis conditions are shown in Table 4.
  • Example 2 The results are shown in FIG. With control H 2 O and Tris alone, data of 12 types of polyamines immediately after addition and after 2 weeks changed, but EDTA alone or a mixed storage solution (mix) of EDTA and Tris can be stably stored It was confirmed that it can be used as a storage solution that can withstand actual analysis.
  • EDTA alone can be stably stored and transported at room temperature, and can be used as a storage solution that can be used for physicochemical analysis of chemical substances such as polyamines.
  • Sample collection containers that allow samples to be collected at various locations, sample transport containers that allow samples to be transported at room temperature, and sample storage that enables samples to be stored at room temperature We can expect products that combine containers.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

[Problem] To provide a preservation solution that can be safely stored and transported at room temperature, and that preserves samples in a condition that allows at least one of following to be carried out: microbial population analysis in which a molecular biological technique is used; and physical and chemical analysis of chemical substances such as organic acids and polyamine. In addition, to provide a method for preserving chemical substances using the preservation solution. [Solution] Provided is a preservation solution for DNA or a chemical substance, characterized by being formed by mixing at least one selected from the group consisting of 3 types of reagents: 4 mol/dm3 of guanidine thiocyanate; 0.1 mol/dm3 of Tris-HCl having a pH of 7.0-9.0; and 0.04 mol/dm3 of EDTA. Also provided is a method for preserving a sample DNA or chemical substance using the preservation solution.

Description

保存溶液およびその保存溶液を用いた検体の保存方法、特に、検体のDNAおよび有機酸やポリアミン類などの化学物質の保存溶液およびその保存溶液を用いた保存方法Preservation solution and method for preserving specimen using the preservation solution, particularly preservation solution for specimen DNA and chemical substances such as organic acids and polyamines, and preservation method using the preservation solution

 本発明は、ヒトや動物などの生体中や水系、土壌、大気などの環境中に存在するDNAや有機酸やポリアミン類などの化学物質の少なくとも一方を室温(摂氏1~40℃程度)で安定的に保存可能な保存溶液に関する。また本保存溶液を用いた検体の保存方法に関する。 In the present invention, at least one of chemical substances such as DNA, organic acids and polyamines present in living bodies such as humans and animals and in environments such as water systems, soils, and air is stable at room temperature (about 1 to 40 ° C.). Relates to a preservable storage solution. The present invention also relates to a specimen storage method using the storage solution.

 現在、微生物は地球上に存在する1%程度しか分離できていないとされ、残りの99%は、「生きているけれども培養できない」状態にあることを指すVNC(viable but non-culturable)状態と呼ばれており、このような培養不能状態にある微生物は培養不能菌や難培養性微生物として理解されている。つまり、培養するために未知の生育因子を要求する微生物や、純粋培養が不可能もしくはきわめて困難な微生物などが多く存在していることを意味している。微生物群集構造の解析には、培養を介す必要がないDNAを用いた様々な分子生物学的手法が開発・利用されている。しかし、検体の採取から解析までの保管の温度や方法により、微生物群集構造が採取時点と異なるといった問題があった。採取時点の検体中の微生物群集のDNAに変化を与えずに、該DNAを室温で安定的に保存・輸送することは、真の微生物群集構造を知るうえで重要な課題である。 Currently, microorganisms are considered to be able to separate only about 1% existing on the earth, and the remaining 99% are in a VNC (viable but non-culturable) state, which means that they are in a “living but unculturable” state. Such microorganisms that are incapable of culturing are understood as unculturable microorganisms and difficult-to-cultivate microorganisms. In other words, it means that there are many microorganisms that require unknown growth factors for culturing and microorganisms that are impossible or extremely difficult to purely culture. For the analysis of the microbial community structure, various molecular biological techniques using DNA that do not require culturing have been developed and used. However, there has been a problem that the microbial community structure differs from that at the time of collection depending on the temperature and method of storage from the collection of the specimen to analysis. It is an important issue to know the true microbial community structure to stably store and transport the DNA at room temperature without changing the DNA of the microbial community in the specimen at the time of collection.

 このDNAを用いた様々な分子生物学的手法には、リアルタイムPCR解析、次世代シーケンサーによるメタゲノム解析、T-RFLP解析やDGGE解析などの微生物群集構造解析および微生物培養株のDNA塩基配列解析や菌株の識別を行うDNA多型性解析の手法であるRAPD解析、マイクロサテライト解析などがある。 Various molecular biological methods using this DNA include real-time PCR analysis, metagenomic analysis using next-generation sequencers, microbial community structure analysis such as T-RFLP analysis and DGGE analysis, DNA base sequence analysis of microorganism culture strains and strains There are RAPD analysis and microsatellite analysis, which are DNA polymorphism analysis methods for identifying the above.

 近年、微生物群集構造解析だけではなく、生体や生物由来の化学物質の内の代謝物質を網羅的に分析および解析手法は、生体中や環境中などの代謝活性を総合的に解明する研究に利用され始めた。この代謝物質の網羅的な分析および解析手法はメタボローム解析と呼ばれ、盛んに行なわれるようになってきている。 In recent years, not only microbial community structure analysis, but also comprehensive analysis and analysis techniques of metabolites in living organisms and biological chemicals have been used for research to comprehensively elucidate metabolic activities in living organisms and the environment. Began to be. This comprehensive analysis and analysis method for metabolites is called metabolomic analysis and has been actively performed.

 化学物質を定量的に分析する方法には、液体クロマトグラフィー、ガスクロマトグラフィー、キャピラリー電気泳動と、それらの質量分析計とを組み合わせた分析などがある。 Quantitative analysis of chemical substances includes liquid chromatography, gas chromatography, capillary electrophoresis, and analysis combining these mass spectrometers.

 従来、微生物群集構造解析や有機酸やポリアミン類などの化学物質の分析を実施する際には、微生物の増殖や死滅・分解および化学物質の酸化、分解、揮発などを抑えるために、検体の採取直後に冷凍して保存することが一般的であった。そのため、冷凍設備の設置が困難な場所での検体採取は事実上不可能であり、また衛生上の問題から糞便などの生体由来の検体を冷凍して保存することが困難な家庭などにおいても検体採取は苦労が多かった。 Conventionally, when conducting analysis of microbial community structure and chemical substances such as organic acids and polyamines, sample collection is required to suppress the growth, death, and decomposition of microorganisms and the oxidation, decomposition, and volatilization of chemical substances. It was common to store frozen immediately. Therefore, it is virtually impossible to collect specimens in places where refrigeration equipment is difficult to install, and specimens can also be used in homes where it is difficult to freeze and store biological specimens such as feces due to sanitary problems. The collection was difficult.

 また、冷凍した検体と採取直後の検体とを比較したところ、変化しやすい微生物群集が存在することや冷凍して保存している時および、前処理時に伴う凍結融解の際に有機酸量が変化するなどの問題があった。 In addition, when comparing frozen samples with samples immediately after collection, the presence of microbial communities that change easily, the amount of organic acid changes when frozen and stored, and during freezing and thawing during pretreatment There was a problem such as.

 冷凍設備がない場合には、採取時の状態を反映した微生物群集構造解析や有機酸、ポリアミン類などの理化学分析を行うためには、冷蔵保管のうえで直ちに前処理・解析や分析に取り掛からなければならず、解析や分析の前準備や多検体の処理への対応が煩雑になり、多くの時間を要する場合には、直ちに解析や分析をすることは困難であった。 In the absence of refrigeration equipment, pretreatment, analysis and analysis should be started immediately after refrigerated storage in order to conduct microbial community structure analysis reflecting the state at the time of collection and physicochemical analysis of organic acids, polyamines, etc. In other words, preparation for analysis and analysis and handling of a large number of specimens become complicated, and when much time is required, it is difficult to immediately analyze and analyze.

 このような背景から、発明者らは採取した検体を、タンパク質変性剤、DNA分解酵素の不活性化剤、キレート剤などを含む水溶液中で、生物の細胞壁のタンパク質を変性させることで増殖できない状態にしてDNAの再合成・分解を抑えることにより、採取時点の生物群集構造に変化を与えず、生物群集や培養株などのDNAを室温で安定的に保存・輸送可能な保存溶液の開発を行ってきた。 From such a background, the inventors cannot proliferate the collected specimen by denaturing the biological cell wall protein in an aqueous solution containing a protein denaturant, a DNA degrading enzyme inactivator, a chelating agent, etc. Development of a storage solution that can stably store and transport DNA of biological communities and culture strains at room temperature without affecting the structure of biological communities at the time of collection by suppressing DNA resynthesis and degradation. I came.

 その結果、微生物群集由来のDNAを安定的に保存・輸送する目的で、発明者らが従来から強力なたんぱく質変性剤として知られる4mol/dm guanidine thiocyanateに、酵素の不活性剤として0.1mol/dm3 Tris-HCl (pH9.0)とキレート剤として0.04mol/dm3 EDTAを添加した保存溶液の中に検体を浸す方法を提案した(非特許文献1参照)。 As a result, for the purpose of stably storing and transporting DNA derived from microbial communities, the inventors have conventionally added 0.1 mol as an enzyme inactivator to 4 mol / dm 3 guanidine thiocynate, which has been known as a powerful protein denaturant. A method has been proposed in which the specimen is immersed in a storage solution to which 0.04 mol / dm 3 EDTA is added as a chelating agent and / dm 3 Tris-HCl (pH 9.0) (see Non-Patent Document 1).

 しかし、保存溶液中のguanidine thiocyanateの濃度についての詳しい検討は実施していなかったことから、この点を鋭意検討した結果、発明者らは保存溶液中のguanidine thiocyanateの濃度を低くすることが可能であることを見出した。低価格化、DNAのPCR増幅の効率化および人体への影響などの取り扱いリスクの低減、また感染症検体の輸送について、感染症の予防および感染症の患者に対する医療に関する法律による輸送の制限に該当しない安全性を考慮した輸送方法、といった事柄が可能になった。(特許文献1参照)。 However, since detailed studies on the concentration of guanidine thiothionate in the preservation solution were not carried out, as a result of earnest examination of this point, the inventors were able to reduce the concentration of guanidine thiothionate in the preservation solution. I found out. Reduced costs, increased efficiency of PCR amplification of DNA and reduced handling risks such as effects on the human body, and transport of infectious disease specimens falls under the prevention of infectious diseases and restrictions on transportation by medical laws for patients with infectious diseases Transportation methods that take safety into account are now possible. (See Patent Document 1).

Koji NAGASHIMA, Daisuke YASOKAWA, Kentaro ABE, Ryoji NAKAGAWA,Tooru KITAMURA,Toshiharu MIURA,Shu KOGAWA, Effect of a Lactobacillus species on incidence of diarrhea in calves and change of the microflora associated with growth, Bioscience Microflora,2010, 29(2), 97-110.Koji NAGASHIMA, Daisuke YASOKAWA, Kentaro ABE, Ryoji NAKAGAWA, Tooru KITAMURA, Toshiharu MIURA, Shu KOGAWA, Effect of a Lactobacillus species on incidence of diarrhea in calves micro , 97-110.

NAGASHIMA (K.), HISADA (T.), SATOU (M.), MOCHIZUKI (J.), Application of New Primer-Enzyme Combination to Terminal Restriction Fragment Length Polymorphism Profiling of Bacterial Populations in Human Feces. Appl. Environ. Microbiol., 2003, 69, 1251-1262.NAGASHIMA (K.), HISADA (T.), SATOU (M.), MOCHIZUKI (J.), Application of New Primer-Enzyme Combination to Terminal Restriction Fragment Length Polymorphism Profiling Environmental ., 2003, 69, 1251-1262.

NAGASHIMA (K.), MOCHIZUKI (J.), HISADA (T.), SUZUKI (S.), SHIMOMURA (K.), Phylogenetic analysis of 16S ribosomal RNA gene sequences from Human fecal microbiota and improved utility of terminal restriction fragment length polymorphism profiling. Bioscience Microflora, 2006, 25, 99-107.NAGASHIMA (K.), MOCHIZUKI. (J.), HISADA (T.), SUZUKI (S.), SHIMOMURA (K.), Phylogenetic analysis of 16S ribosomal RNA gene sequences fromcal microbiotautility polymorphism profiling. Bioscience Microflora, 2006, 25, 99-107.

特開2016-136911号公報JP 2016-136911 A

 一方、理化学分析用に有機酸やポリアミン類などの化学物質を室温で安定的に保存・輸送することを可能な状態で検体を保存する保存溶液がなく、さらに分子生物学的手法を用いた微生物群集解析と、理化学分析と、の少なくとも一方を実施可能な状態で検体を保存する保存溶液及びその保存溶液を用いた保存方法がなかった。 On the other hand, there is no storage solution for storing specimens in a state where chemical substances such as organic acids and polyamines can be stably stored and transported at room temperature for physicochemical analysis, and microorganisms using molecular biological techniques There was no storage solution for storing a specimen in a state where at least one of a crowd analysis and a physicochemical analysis could be performed, and a storage method using the storage solution.

 このようなことから、室温で安定的に保存・輸送ができ、分子生物学的手法を用いた微生物群集解析と、有機酸やポリアミン類などの化学物質の理化学分析と、の少なくとも一方を実施可能な状態で検体を保存する保存溶液の開発が望まれていた。 Because of this, it can be stored and transported stably at room temperature, and at least one of microbial community analysis using molecular biological techniques and physicochemical analysis of chemical substances such as organic acids and polyamines can be performed. It has been desired to develop a storage solution for storing the specimen in a stable state.

 さらに、糞便検体の場合、理化学分析においては分子生物学的手法に比べてより多くの検体量が必要になる一方で、保存・輸送の面から容器の大きさを小さく抑える必要もある。つまり検体採取による保存溶液中のguanidine thiocyanate濃度の低下によるDNAおよび、有機酸やポリアミン類などの化学物質の保存への影響および保存溶液と検体の混合効率を考慮しなければならないために、検体量に対する保存溶液量の比率とその比率に最適なguanidine thiocyanate濃度を設定しておく必要があった。 Furthermore, in the case of stool specimens, a larger amount of specimen is required in physicochemical analysis than in molecular biological techniques, while the size of the container must be kept small in terms of storage and transportation. In other words, the amount of the sample must be taken into consideration due to the effect on the preservation of DNA and chemical substances such as organic acids and polyamines due to the decrease in the concentration of guanidine thiothionate in the preservation solution by the specimen collection, and the mixing efficiency of the preservation solution and the specimen. It was necessary to set an optimal guanidine thiothionate concentration for the ratio of the storage solution amount to the ratio and the ratio.

 本発明は、上記のような要望に応えることができるものであって、以下の構成からなる発明である。すなわち、
(1)4mol/dm guanidine thiocyanateと、pH7.0以上から9.0以下の0.1mol/dm3 Tris-HClと、0.04mol/dm3 EDTAと、からなる3種類の試薬群より、少なくとも1種類以上の選ばれる試薬を混合してなる保存溶液である。なお、0.1mol/dm Tris-HClはpH8.0とすることがより好適である。
(2)上述した保存溶液の構成に加え、DNAと、有機酸やポリアミン類の化学物質と、の少なくとも一方を保存することを特徴とする保存溶液。
(3)上述した構成の保存溶液を、保存溶液を検体に添加し、前記検体を室温で保存することを特徴とする保存方法である。
(4)上述した保存方法の構成に加え、保存溶液が4mol/dmguanidine thiocyanateの試薬を含み、前記保存溶液を検体に添加された後、前記保存溶液のguanidine thiocyanateの終濃度が0.01mol/dm以上とするとともに、前記保存溶液の容量に対して前記検体の容量を50%以下とすることを特徴とする保存方法である。なお、guanidine thiocyanateの終濃度を0.15mol/dm~0.75mol/dmにすること、検体の容量が保存溶液の容量に対して25%以下にすること、がより好適である。
The present invention can meet the above-mentioned demands, and has the following configuration. That is,
(1) From three types of reagent groups consisting of 4 mol / dm 3 guanidine thiocynate, 0.1 mol / dm 3 Tris-HCl having a pH of 7.0 to 9.0, and 0.04 mol / dm 3 EDTA, It is a preservation solution obtained by mixing at least one selected reagent. In addition, 0.1 mol / dm 3 Tris-HCl is more preferably set to pH 8.0.
(2) A storage solution characterized by storing at least one of DNA and a chemical substance such as an organic acid or polyamines in addition to the above-described configuration of the storage solution.
(3) A storage method comprising: adding a storage solution having the above-described configuration to a specimen, and storing the specimen at room temperature.
(4) In addition to the configuration of the storage method described above, the storage solution contains 4 mol / dm 3 guanidine thiocynate reagent, and after the storage solution is added to the specimen, the final concentration of guanidine thiocynate in the storage solution is 0.01 mol. / Dm 3 or more, and the volume of the specimen is 50% or less with respect to the volume of the storage solution. Note that the final concentration of guanidine thiocyanate in 0.15mol / dm 3 ~ 0.75mol / dm 3, the capacity of the specimen is below 25% relative to volume of the stock solution, but it is more preferable.

 請求項1及び2記載の発明によれば、DNAと、化学物質と、の少なくとも一方を室温で安定的に保存することができる新規の保存溶液を提供することが可能であり、とりわけ、DNAおよびDNA構成比、又は、有機酸やポリアミン類などの化学物質、又は、DNAおよびDNA構成比並びに有機酸やポリアミン類などの化学物質、を保存することが可能な保存溶液を提供することが可能である。 According to the first and second aspects of the present invention, it is possible to provide a novel storage solution capable of stably storing at least one of DNA and a chemical substance at room temperature. It is possible to provide a preservation solution capable of preserving DNA constituent ratios or chemical substances such as organic acids and polyamines, or DNA and DNA constituent ratios and chemical substances such as organic acids and polyamines. is there.

 請求項3記載の発明によれば、検体のDNAと、有機酸やポリアミン類の化学物質と、の少なくとも一方を室温で安定的に保存する保存方法を新規に提供することが可能である。 According to the invention described in claim 3, it is possible to newly provide a storage method for stably storing at least one of a sample DNA and an organic acid or a chemical compound of polyamines at room temperature.

 請求項4記載の発明によれば、検体のDNAと、化学物質と、の少なくとも一方を室温で安定的に保存・輸送ができ、分子生物学的手法を用いた微生物群集構造解析、DNAおよびDNA構成比、有機酸やポリアミン類などの化学物質の理化学分析に、溶液に浸けた検体の少なくとも一方を利用することができる保存方法を新規に提供することが可能である。 According to the invention of claim 4, at least one of the sample DNA and the chemical substance can be stably stored and transported at room temperature, and the microbial community structure analysis, DNA and DNA using molecular biological techniques It is possible to newly provide a storage method that can use at least one of the specimens immersed in a solution for the physicochemical analysis of chemical substances such as composition ratios, organic acids, and polyamines.

「分子生物学的手法 T-RFLP解析による、冷凍保存と各guanidine thiocyanateの終濃度の保存溶液での30℃、7日間保存後の糞便の微生物群集構造(菌叢)比較」についての被験者Aの図である。縦軸は各種菌種の糞便中での存在割合を示している。"Comparison of fecal microbial community structure (fungal flora) after storage for 7 days at 30 ° C in a storage solution at the final concentration of each of guanidineine thiocynate by freezing and T-RFLP analysis" FIG. The vertical axis shows the abundance ratio of various bacterial species in feces. 「分子生物学的手法 T-RFLP解析による、冷凍保存と各guanidine thiocyanateの終濃度の保存溶液での30℃、7日間保存後の糞便の微生物群集構造(菌叢)比較」についての被験者Bの図である。縦軸は各種菌種の糞便中での存在割合を示している。"Comparison of fecal microbial community structure (fungal flora) after storage for 7 days at 30 ° C in a storage solution at the final concentration of frozen storage and each guanidine thiocynate by molecular biological method T-RFLP analysis" FIG. The vertical axis shows the abundance ratio of various bacterial species in feces. 「理化学分析による、冷凍保存と各guanidine thiocyanateの終濃度の保存溶液での30℃、7日間保存後の糞便の有機酸比較」についての被験者Aの図である。It is the figure of the test subject A about "the organic acid of the stool after 30 days and 30 degreeC preservation | save with the preservation | save solution of 30 degreeC and the preservation | save solution of the final density | concentration of each guanidine thiocynate by the physical and chemical analysis. 「理化学分析による、冷凍保存と各guanidine thiocyanateの終濃度の保存溶液での30℃、7日間保存後の糞便の有機酸比較」についての被験者Bの図である。It is the figure of the test subject B about "comparison of the organic acid of the stool after a freezing preservation | save and the preservation | save solution of the final concentration of each guanidineinethiocynate by 30 days at 30 degreeC by a physicochemical analysis." 「理化学分析による、HO保存と各保存液での室温保存後の唾液中ポリアミン」についての図である。図中のmixとは、EDTAとTrisの混合溶液である。"By physicochemical analysis, saliva polyamine after room temperature storage of with H 2 O saved and the preservation solution" is a diagram for. The mix in the figure is a mixed solution of EDTA and Tris.

(実施形態)
 本発明の好ましい実施形態について詳細に説明する。
(Embodiment)
A preferred embodiment of the present invention will be described in detail.

 本実施形態における保存溶液は、4mol/dm guanidine thiocyanateと、pH7.0以上から9.0以下の0.1mol/dm3 Tris-HClと、0.04mol/dm3 EDTAと、からなる3種類の試薬群より、少なくとも1種類以上の選ばれる試薬を混合してなることを特徴とするものである。なお、0.1mol/dm Tris-HClはpH8.0とすることがより好適である。 The preservation solution in the present embodiment includes three types consisting of 4 mol / dm 3 guanidine thiocynate, pH 7.0 to 9.0 mol 0.1 mol / dm 3 Tris-HCl, and 0.04 mol / dm 3 EDTA. From the reagent group, at least one selected reagent is mixed. In addition, 0.1 mol / dm 3 Tris-HCl is more preferably set to pH 8.0.

 本実施形態における保存方法は、上述した保存溶液を検体に添加し、前記検体のDNAと、有機酸やポリアミン類の化学物質と、の少なくとも一方を室温で保存することを特徴とするものである。 The storage method in the present embodiment is characterized in that the above-described storage solution is added to a specimen, and at least one of the DNA of the specimen and a chemical substance such as an organic acid or a polyamine is stored at room temperature. .

 また、上述した保存方法は、保存溶液が4mol/dmguanidine thiocyanateの試薬を含み、前記保存溶液を検体に添加された後、前記保存溶液のguanidine thiocyanateの終濃度が0.01mol/dm以上とするとともに、前記保存溶液の容量に対して前記検体の容量を50%以下とすることを特徴とすることが好ましい。なお、guanidine thiocyanateの終濃度を0.15mol/dm~0.75mol/dmにすること、検体の容量が保存溶液の容量に対して25%以下にすることがより好適である。 Further, in the storage method described above, the storage solution contains 4 mol / dm 3 guanidine thiocynate reagent, and after the storage solution is added to the specimen, the final concentration of guanidine thiocynate in the storage solution is 0.01 mol / dm 3 or more. In addition, it is preferable that the volume of the specimen is 50% or less with respect to the volume of the storage solution. Note that the final concentration of guanidine thiocyanate in 0.15mol / dm 3 ~ 0.75mol / dm 3, and more preferably be 25% or less with respect to the capacity of the storage of the sample solutions.

 なお、検体は、様々な生物を含む、環境由来の検体の土壌、汚泥、液体などや生体由来の検体の糞便、唾液、血液などを含むものある。 Samples include soils, sludges, liquids, etc. of environmental samples including various organisms, and feces, saliva, blood, etc. of biological samples.

 上述した実施形態に基づいて作成した保存溶液及びその保存溶液を用いた保存方法の作用効果を示すために後述する実験(実験方法1、実験方法2)を行った。 Experiments (Experiment Method 1 and Experiment Method 2) to be described later were performed in order to demonstrate the operational effects of the preservation solution prepared based on the above-described embodiment and the preservation method using the preservation solution.

 (実験方法1)
 被験者2名において、排便後、直ぐに冷凍保管した糞便検体と、guanidine thiocyanateの濃度を1mol/dm(糞便採取後の終濃度0.75mol/dm)、0.6mol/dm(糞便採取後の終濃度0.45mol/dm)、0.4mol/dm(糞便採取後の終濃度0.30mol/dm)、0.2mol/dm(糞便採取後の終濃度0.15mol/dm)の4種類になるように調整し、0.1mol/dm Tris-HCl(pH8.0)と、0.04mol/dm EDTAと、を混合した4種類の各guanidine thiocyanate濃度の保存溶液中に、糞便濃度(検体量)が250g/dm(25%)になるように採便した。そして、採便した採取物を30℃で7日間保存した後、T-RFLP解析による微生物群集構造(菌叢)比較および液体クロマトグラフィーによる有機酸量比較(コハク酸、乳酸、蟻酸、酢酸、プロピオン酸、iso-酪酸、n-酪酸、iso-吉草酸、n-吉草酸)を行った。検討条件を表1に示す。
(Experiment Method 1)
In two subjects, the concentration of stool specimens immediately frozen after stool and guanidine thiocynate was 1 mol / dm 3 (final concentration after stool collection 0.75 mol / dm 3 ), 0.6 mol / dm 3 (after stool collection) Final concentration of 0.45 mol / dm 3 ), 0.4 mol / dm 3 (final concentration after stool collection 0.30 mol / dm 3 ), 0.2 mol / dm 3 (final concentration after stool collection 0.15 mol / dm 3 ) 3 ) and 4 kinds of guanidine thiocynate concentration storage solutions prepared by mixing 0.1 mol / dm 3 Tris-HCl (pH 8.0) and 0.04 mol / dm 3 EDTA. The stool was collected so that the stool concentration (specimen amount) was 250 g / dm 3 (25%). The collected stool samples are stored at 30 ° C. for 7 days, followed by comparison of microbial community structure (microflora) by T-RFLP analysis and comparison of organic acids by liquid chromatography (succinic acid, lactic acid, formic acid, acetic acid, propion) Acid, iso-butyric acid, n-butyric acid, iso-valeric acid, n-valeric acid). The examination conditions are shown in Table 1.

 T-RFLP解析による微生物群集構造(菌叢)解析は、糞便中の全細菌DNAを抽出し、細菌16S rRNA遺伝子領域をフォワード側とリバース側のプライマーでどちらかのプライマーを蛍光色素でラベル化し、PCR増幅を行い、制限酵素で切断した後、キャピラリーシーケンサーを用いて切断された蛍光ラベル化末端DNA断片を分画し、各DNA断片の長さと相対量を解析することにより、細菌の群集構造を調べる方法である。 Microbial community structure (microflora) analysis by T-RFLP analysis is to extract the total bacterial DNA in feces, label the bacterial 16S rRNA gene region with forward and reverse primers, and either primer with fluorescent dye, After performing PCR amplification and cleaving with a restriction enzyme, the fluorescently labeled terminal DNA fragments cleaved using a capillary sequencer are fractionated, and the length and relative amount of each DNA fragment are analyzed to determine the bacterial community structure. It is a method of examining.

 本件の検討には、長島らの方法(非特許文献2,3参照)に基づき行った。なお、フラグメント解析にはABI PRISM 3130xl DNA Sequencer(Applied Biosystems,CA,USA)およびGeneMapper(Applied Biosystems, CA, USA)を使用した。各フラグメントの分類はoperational taxonomic unitで判断した。 The examination of this case was based on the method of Nagashima et al. (See Non-Patent Documents 2 and 3). For fragment analysis, ABIBPRISM 3130xl DNA Sequencer (Applied Biosystems, CA, USA) and GeneMapper (Applied Biosystems, CA, USA) were used. The classification of each fragment was judged by the operational taxonomic unit.

 有機酸の理化学分析は、一定量の糞便検体をビーズチューブに精秤し、抽出溶液に懸濁後、熱処理(85℃, 20分)した。ビーズビーターにより検体を破砕した後、233.3 rpsで10分間遠心し、上清を孔径0.45μmのメンブランフィルターで濾過し、これを検体溶液として高速液体クロマトグラムで分析した。分析条件を表2に示す。 In the physicochemical analysis of organic acids, a certain amount of stool specimen was precisely weighed in a bead tube, suspended in an extraction solution, and then heat-treated (85 ° C., 20 minutes). The sample was crushed with a bead beater, centrifuged at 233.3 rps for 10 minutes, the supernatant was filtered through a membrane filter with a pore size of 0.45 μm, and this was analyzed as a sample solution by a high performance liquid chromatogram. The analysis conditions are shown in Table 2.

Figure JPOXMLDOC01-appb-T000001
Figure JPOXMLDOC01-appb-T000001

Figure JPOXMLDOC01-appb-T000002
Figure JPOXMLDOC01-appb-T000002

(実験結果1)
 その結果を、図1から図4に示した。微生物群集構造(菌叢)解析および有機酸の理化学分析の何れにおいても、2名の被験者において、0.2mol/dm以上(糞便採取後の終濃度0.15mol/dm以上)のどの保存溶液でも、微生物群集構造(菌叢)および各種有機酸の量が保存されており、冷凍保管と差がないことが示された。該被験者においてはiso-酪酸、iso-吉草酸、n-吉草酸は検出されなかった。しかし、他の被験者での0.2mol/dm保存溶液を用いた同試験では、iso-酪酸、iso-吉草酸、n-吉草酸も安定的に保持されることが示されている(データ非掲載)。
(Experimental result 1)
The results are shown in FIGS. In both the microbial community structure (bacteria flora) analysis and the physicochemical analysis of organic acids, in 2 subjects, which preservation of 0.2 mol / dm 3 or more (final concentration after stool collection 0.15 mol / dm 3 or more) The solution also preserved the microbial community structure (bacteria flora) and the amount of various organic acids, indicating that there was no difference from frozen storage. In the subject, iso-butyric acid, iso-valeric acid, and n-valeric acid were not detected. However, the same study using 0.2 mol / dm 3 stock solution in other subjects showed that iso-butyric acid, iso-valeric acid, and n-valeric acid were also stably retained (data) Not shown).

 以上の結果より、0.1mol/dm Tris-HCl(pH8.0)、0.04mol/dm EDTAと0.2mol/dm~1mol/dmのguanidine thiocyanateを含む溶液に、guanidine thiocyanateの糞便採取後の終濃度が0.15mol/dm~0.75mol/dmになるように糞便を採取することで、分子生物学的手法を用いた微生物群集構造(菌叢)解析および有機酸の理化学分析のための糞便を、冷凍保管と同様に室温で7日間、維持・保存できることが確認できた。 From the above results, guanidine thiocynate was added to a solution containing 0.1 mol / dm 3 Tris-HCl (pH 8.0), 0.04 mol / dm 3 EDTA and 0.2 mol / dm 3 to 1 mol / dm 3 of guanidine thiocynate. by final concentration after stool collection to collect feces to be 0.15mol / dm 3 ~ 0.75mol / dm 3, microbial community structure (lawn) analysis and organic acids using molecular biology techniques It was confirmed that feces for physicochemical analysis can be maintained and stored at room temperature for 7 days in the same manner as frozen storage.

 また、微生物群集構造を維持・保存できることから、感染症検体や臨床検体の微生物の細胞膜を溶かし、増殖や感染ができない状態にすることで、輸送の制限がなく、安全に取り扱うことが可能となり、様々な分子生物学的手法を用いた微生物群集構造(菌叢)解析や微生物の遺伝子解析(同定、分類、株識別)などに利用できることも確認できた。 In addition, since the microbial community structure can be maintained and preserved, by dissolving the cell membranes of the microorganisms of infectious disease samples and clinical samples to make them unable to grow or infect, it becomes possible to handle safely without restrictions on transportation. It was also confirmed that it can be used for microbial community structure (bacteria flora) analysis and microbial gene analysis (identification, classification, strain identification) using various molecular biological techniques.

 さらに、有機酸を維持・保存できることから、感染症検体や臨床検体の微生物の細胞膜を溶かし増殖や感染ができない状態にすることで、輸送の制限がなく、安全に取り扱うことが可能となり、有機酸の様々な手法による理化学分析に利用できることも確認できた。 In addition, since organic acids can be maintained and preserved, by dissolving the cell membranes of microorganisms in infectious disease samples and clinical samples so that they cannot grow or infect, it becomes possible to handle them safely without restrictions on transportation. It was also confirmed that it can be used for physicochemical analysis by various methods.

 このことから、室温で安定的に保存・輸送ができ、分子生物学的手法を用いた微生物群集構造(菌叢)解析と有機酸などの理化学分析との少なくとも一方を実施可能な解析・分析に利用できることが可能となった。 This enables analysis and analysis that can be stably stored and transported at room temperature, and can perform at least one of microbial community structure (bacteria flora) analysis using molecular biological techniques and physicochemical analysis such as organic acids. It became possible to use it.

 そして、微生物群集構造を維持・保存できることから、リアルタイムPCR解析、次世代シーケンサーによるメタゲノム解析、T-RFLP解析やDGGE解析などの微生物群集構造解析および生物培養株のDNA塩基配列解析や菌株の識別を行うDNA多型性解析の手法であるRAPD解析、マイクロサテライト解析などのDNAを用いた様々な分子生物学的手法に利用できることも確認でき、検体を様々な場所において採取することを可能とする検体の採取容器、検体を室温で輸送することを可能とする検体の輸送容器、検体を室温で保管することを可能とする検体の保管容器などの組み合わせた製品が期待できる。また、感染症検体や臨床検体にも対応可能な製品が期待できる。 And since microbial community structure can be maintained and preserved, real-time PCR analysis, metagenomic analysis using next-generation sequencers, microbial community structure analysis such as T-RFLP analysis and DGGE analysis, DNA base sequence analysis of biological culture strains and strain identification Specimens that can be used for various molecular biology techniques using DNA such as RAPD analysis and microsatellite analysis, which are DNA polymorphism analysis techniques to be performed, and that enable specimens to be collected at various locations A combined product such as a collection container, a specimen transport container that enables the specimen to be transported at room temperature, and a specimen storage container that enables the specimen to be stored at room temperature can be expected. In addition, products that can handle infectious disease samples and clinical samples can be expected.

(実験方法2)
 次に、唾液30mmに1.5μmol/dmポリアミン類の標品30mmおよびコントロールとしてHO、対照区として各保存溶液30mmを加えた唾液検体を作成し、添加直後および室温で1~2週間保存後におけるポリアミン類の変化を測定した。保存溶液の検討条件を表3に示す。
(Experiment Method 2)
Next, a saliva specimen was prepared by adding 1.5 μmol / dm 3 polyamines standard 30 mm 3 to saliva 30 mm 3 and H 2 O as a control, and each storage solution 30 mm 3 as a control, and immediately after addition and at room temperature. Changes in polyamines after storage for ˜2 weeks were measured. Table 3 shows the conditions for studying the stock solution.

Figure JPOXMLDOC01-appb-T000003
Figure JPOXMLDOC01-appb-T000003

 ポリアミン類の理化学分析は、各唾液検体にアセトニトリル(MeCN)120mmと70nmol/dmジアミノヘキサンを加え除タンパクのうえ、3000g 5分間遠心分離後、上清液を検体溶液とし、40mmol/dmDBD-Fのアセトニトリル溶液90mmと100mmol/dmトリエチルアミンの水溶液60mmを入れ、60℃ 30分でポリアミンを誘導体化後、高速液体クロマトグラム質量分析計によりポリアミン類の12種類を分析した。分析条件を表4に示す。 The physicochemical analysis of polyamines was carried out by adding acetonitrile (MeCN) 120 mm 3 and 70 nmol / dm 3 diaminohexane to each saliva sample, deproteinizing it, centrifuging at 3000 g for 5 minutes, and using the supernatant as the sample solution, 40 mmol / dm 3 DBD-F in acetonitrile (90 mm 3) and 100 mmol / dm 3 triethylamine aqueous solution (60 mm 3) were added, and after derivatizing the polyamine at 60 ° C. for 30 minutes, 12 types of polyamines were analyzed by a high performance liquid chromatogram mass spectrometer. The analysis conditions are shown in Table 4.

Figure JPOXMLDOC01-appb-T000004
Figure JPOXMLDOC01-appb-T000004

(実験結果2)
 その結果を、図5に示した。コントロールHOやTris単独では、添加直後と2週間後のポリアミン類の12種類がデータに変動がみられたが、EDTA単独およびEDTAとTrisの混合保存溶液(mix)では安定的に保存できることが確認でき、実分析に耐えうる保存溶液として利用できることが確認できた。
(Experimental result 2)
The results are shown in FIG. With control H 2 O and Tris alone, data of 12 types of polyamines immediately after addition and after 2 weeks changed, but EDTA alone or a mixed storage solution (mix) of EDTA and Tris can be stably stored It was confirmed that it can be used as a storage solution that can withstand actual analysis.

 このことから、EDTA単独により、室温で安定的に保存・輸送ができ、ポリアミン類などの化学物質の理化学分析に実施可能な保存溶液に利用できることが可能となった。 Therefore, EDTA alone can be stably stored and transported at room temperature, and can be used as a storage solution that can be used for physicochemical analysis of chemical substances such as polyamines.

 そして、検体を様々な場所において採取することを可能とする検体の採取容器、検体を室温で輸送することを可能とする検体の輸送容器、検体を室温で保管することを可能とする検体の保管容器などを組み合わせた製品が期待できる。 Sample collection containers that allow samples to be collected at various locations, sample transport containers that allow samples to be transported at room temperature, and sample storage that enables samples to be stored at room temperature We can expect products that combine containers.

 有機酸やポリアミン類などの化学物質を維持・保存できることから、液体クロマトグラフィー、ガスクロマトグラフィー、キャピラリー電気泳動とそれらの質量分析計と組み合わせた理化学分析に利用できることも確認でき、検体を様々な場所において採取することを可能とする検体の採取容器、検体を室温で輸送することを可能とする検体の輸送容器、検体を室温で保管することを可能とする検体の保管容器などを組み合わせた製品が期待できる。
 
Since chemical substances such as organic acids and polyamines can be maintained and stored, it can be confirmed that they can be used for physicochemical analysis in combination with liquid chromatography, gas chromatography, capillary electrophoresis and their mass spectrometers, and samples can be used in various places. A product that combines a sample collection container that can be collected at room temperature, a sample transport container that enables the sample to be transported at room temperature, and a sample storage container that enables the sample to be stored at room temperature. I can expect.

Claims (4)

 4mol/dm guanidine thiocyanateと、pH7.0以上から9.0以下の0.1mol/dm3 Tris-HClと、0.04mol/dm3 EDTAと、からなる3種類の試薬群より、少なくとも1種類以上の選ばれる試薬を混合してなる保存溶液。 At least one kind from three kinds of reagent groups consisting of 4 mol / dm 3 guanidine thiocynate, pH 7.0 or more and 9.0 or less 0.1 mol / dm 3 Tris-HCl, and 0.04 mol / dm 3 EDTA A preservation solution obtained by mixing the above selected reagents.  DNAと、有機酸やポリアミン類の化学物質と、の少なくとも一方を保存することを特徴とする請求項1記載の保存溶液。 2. The preservation solution according to claim 1, wherein at least one of DNA and a chemical substance such as an organic acid or a polyamine is preserved.  請求項1又は2のいずれか一項に記載の保存溶液を検体に添加し、前記検体を室温で保存することを特徴とする保存方法。 A storage method comprising: adding the storage solution according to claim 1 or 2 to a specimen, and storing the specimen at room temperature.  保存溶液が4mol/dmguanidine thiocyanateの試薬を含み、前記保存溶液を検体に添加された後、前記保存溶液のguanidine thiocyanateの終濃度が0.01mol/dm以上とするとともに、前記保存溶液の容量に対して前記検体の容量を50%以下とすることを特徴とする請求項3記載の保存方法。
 
The preservation solution contains a reagent of 4 mol / dm 3 guanidine thiocynate, and after the preservation solution is added to the specimen, the final concentration of guanidine thiocynate in the preservation solution is 0.01 mol / dm 3 or more. The storage method according to claim 3, wherein the volume of the specimen is 50% or less with respect to the volume.
PCT/JP2017/003189 2017-01-30 2017-01-30 Preservation solution and sample preservation method using said preservation solution, in particular preservation solution for sample dna and chemical substance such as organic acid or polyamine and preservation method using said preservation solution Ceased WO2018138913A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/JP2017/003189 WO2018138913A1 (en) 2017-01-30 2017-01-30 Preservation solution and sample preservation method using said preservation solution, in particular preservation solution for sample dna and chemical substance such as organic acid or polyamine and preservation method using said preservation solution

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2017/003189 WO2018138913A1 (en) 2017-01-30 2017-01-30 Preservation solution and sample preservation method using said preservation solution, in particular preservation solution for sample dna and chemical substance such as organic acid or polyamine and preservation method using said preservation solution

Publications (1)

Publication Number Publication Date
WO2018138913A1 true WO2018138913A1 (en) 2018-08-02

Family

ID=62979424

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2017/003189 Ceased WO2018138913A1 (en) 2017-01-30 2017-01-30 Preservation solution and sample preservation method using said preservation solution, in particular preservation solution for sample dna and chemical substance such as organic acid or polyamine and preservation method using said preservation solution

Country Status (1)

Country Link
WO (1) WO2018138913A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2021054028A1 (en) * 2019-09-18 2021-03-25

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5277003A (en) * 1975-12-24 1977-06-29 Nippon Oil & Fats Co Ltd Stabilization process of peroxyketones
JPH07278067A (en) * 1994-03-31 1995-10-24 Iatron Lab Inc Method for stabilizing ethanolamine buffer
US5804200A (en) * 1991-02-12 1998-09-08 Colorado State University Research Foundation Parasitic nematode proteins and vaccines
JPH11139967A (en) * 1997-11-07 1999-05-25 Otsuka Pharmaceut Co Ltd Anticoagulant
JP2000505421A (en) * 1996-02-01 2000-05-09 メルク フロスト カナダ アンド カンパニー Alkylated styrene as prodrug of COX-2 inhibitor
JP2007151470A (en) * 2005-12-06 2007-06-21 Toyobo Co Ltd Method for amplifying nucleic acid using sample
JP2012523851A (en) * 2009-04-20 2012-10-11 ロングホーン・バクシーンズ・アンド・ダイアグノステイツクス・エル・エル・シー Biological sample collection / transport composition and method
JP2015501798A (en) * 2011-11-22 2015-01-19 タミンコ Stabilized choline solution and method for preparing the same
JP2016136911A (en) * 2015-01-29 2016-08-04 株式会社テクノスルガ・ラボ Preservation / transportation technology that can maintain the biological community structure, store at room temperature, and transport, and collect / transport / storage containers for specimens using this technology

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5277003A (en) * 1975-12-24 1977-06-29 Nippon Oil & Fats Co Ltd Stabilization process of peroxyketones
US5804200A (en) * 1991-02-12 1998-09-08 Colorado State University Research Foundation Parasitic nematode proteins and vaccines
JPH07278067A (en) * 1994-03-31 1995-10-24 Iatron Lab Inc Method for stabilizing ethanolamine buffer
JP2000505421A (en) * 1996-02-01 2000-05-09 メルク フロスト カナダ アンド カンパニー Alkylated styrene as prodrug of COX-2 inhibitor
JPH11139967A (en) * 1997-11-07 1999-05-25 Otsuka Pharmaceut Co Ltd Anticoagulant
JP2007151470A (en) * 2005-12-06 2007-06-21 Toyobo Co Ltd Method for amplifying nucleic acid using sample
JP2012523851A (en) * 2009-04-20 2012-10-11 ロングホーン・バクシーンズ・アンド・ダイアグノステイツクス・エル・エル・シー Biological sample collection / transport composition and method
JP2015501798A (en) * 2011-11-22 2015-01-19 タミンコ Stabilized choline solution and method for preparing the same
JP2016136911A (en) * 2015-01-29 2016-08-04 株式会社テクノスルガ・ラボ Preservation / transportation technology that can maintain the biological community structure, store at room temperature, and transport, and collect / transport / storage containers for specimens using this technology

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
NAGASHIMA, K. ET AL.: "Effect of a Lactobacillus species on incidence of diarrhea in calves and change of the microflora associated with growth", BIOSCIENCE AND MICROFLORA, vol. 29, no. 2, January 2010 (2010-01-01), pages 97 - 110, XP055548619 *
NAGASHIMA, K. ET AL.: "Phylogenetic analysis of 16S ribosomal RNA gene sequences from human fecal microbiota and improved utility of terminal restriction fragment length polymorphism profiling", BIOSCIENCE AND MICROFLORA, vol. 25, no. 3, 16 March 2006 (2006-03-16), pages 99 - 107, XP055548616 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2021054028A1 (en) * 2019-09-18 2021-03-25
WO2021054028A1 (en) * 2019-09-18 2021-03-25 株式会社テクノスルガ・ラボ Specimen preservation solution and analyzer and analysis method using same
CN114096668A (en) * 2019-09-18 2022-02-25 株式会社骏河生物技术研究所 Specimen preservation solution, and device and method for analysis using same
JP7125579B2 (en) 2019-09-18 2022-08-25 株式会社テクノスルガ・ラボ Specimen storage solution, analysis device and analysis method using the same
US20220333156A1 (en) * 2019-09-18 2022-10-20 Technosuruga Laboratory Co., Ltd. Sample preservation solution, and analysis device and analysis method using the same
EP4047089A4 (en) * 2019-09-18 2023-08-23 Technosuruga Laboratory Co.,Ltd. Specimen preservation solution and analyzer and analysis method using same
CN114096668B (en) * 2019-09-18 2024-04-05 株式会社骏河生物技术研究所 Sample storage liquid, and analysis device and analysis method using same

Similar Documents

Publication Publication Date Title
Semenov Metabarcoding and metagenomics in soil ecology research: achievements, challenges, and prospects
Hale et al. Effect of preservation method on spider monkey (Ateles geoffroyi) fecal microbiota over 8 weeks
Davis Enumeration of probiotic strains: review of culture-dependent and alternative techniques to quantify viable bacteria
Radajewski et al. Stable-isotope probing of nucleic acids: a window to the function of uncultured microorganisms
van Belkum et al. Progress in proteomics for clinical microbiology: MALDI-TOF MS for microbial species identification and more
Li et al. Effects of sample preservation and DNA extraction on enumeration of antibiotic resistance genes in wastewater
Kang et al. The effect of sample size in studies of soil microbial community structure
CN106460030A (en) Composition and method for stabilizing and maintaining the viability of hardy microorganisms
Watsuji et al. Diversity and methane oxidation of active epibiotic methanotrophs on live Shinkaia crosnieri
Walker et al. Single-cell genomics
Lewis et al. Culturing the uncultured
Gaci et al. Functional amplification and preservation of human gut microbiota
AU2006209416A1 (en) Method of quantitatively analysing microorganism targeting rRNA
AU2017335897A1 (en) High resolution systems, kits, apparatus, and methods for bacterial community relationship determination and other high throughput microbiology applications
Hampton-Marcell et al. Preparation and Metatranscriptomic Analyses of Host–Microbe Systems
Nuccio et al. HT-SIP: A semi-automated Stable Isotope Probing pipeline identifies interactions in the hyphosphere of arbuscular mycorrhizal fungi
JP2019520825A (en) High-throughput microbiologically applied high resolution system, kit, apparatus and method using magnetic particles
Park et al. New method to characterize microbial diversity using flow cytometry
JP2016136911A (en) Preservation / transportation technology that can maintain the biological community structure, store at room temperature, and transport, and collect / transport / storage containers for specimens using this technology
CN104099323A (en) DNA (Deoxyribose Nucleic Acid) extraction method for analyzing diversity of yak rumen microbe structure
WO2018138913A1 (en) Preservation solution and sample preservation method using said preservation solution, in particular preservation solution for sample dna and chemical substance such as organic acid or polyamine and preservation method using said preservation solution
Qi et al. Single-cell analysis reveals gene-expression heterogeneity in syntrophic dual-culture of Desulfovibrio vulgaris with Methanosarcina barkeri
Ghori et al. RNA stable isotope probing (RNA-SIP)
Hutchison et al. Polysaccharide-based liquid storage and transport media for non-refrigerated preservation of bacterial pathogens
Zhen et al. Development of a dual-internal-reference technique to improve accuracy when determining bacterial 16S rRNA: 16S rRNA gene ratio with application to Escherichia coli liquid and aerosol samples

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17894037

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 17894037

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP